Aquestive Therapeutics, Inc. (AQST) has a market capitalization of $412.12M and trades at $4.15. The 52-week range is 2.12-7.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.5, Earnings Per Share (EPS) of $-0.76, annual revenue of $44.55M.
The stock has a beta of 1.53, operates in the Healthcare sector.
